Navigation Links
FDA Lifts Clinical Hold on Genta's Tesetaxel, a Leading Oral Taxane
Date:6/23/2008

Clinical Studies Expected to Restart in Second Half 2008

BERKELEY HEIGHTS, N.J., June 23 /PRNewswire-FirstCall/ -- Genta Incorporated (OTC Bulletin Board: GNTA) announced that the Company has received notification from the U.S. Food and Drug Administration (FDA) that Genta may resume clinical trials with tesetaxel, a leading oral taxane in Genta's oncology product portfolio. The notification was made in response to the Company's submission of a complete response to a prior notice from FDA that had placed the drug on "clinical hold".

"We believe tesetaxel may provide an important option for the care of patients with advanced cancer," commented Dr. Loretta M. Itri, Genta's President, Pharmaceutical Development, and Chief Medical Officer. "We are very pleased that FDA found that our initial submission addressed their safety concerns by incorporating careful monitoring and supportive care to reduce risks. We have formulated an innovative development strategy that may enable tesetaxel to become the first oral taxane to receive regulatory approval. We look forward to promptly resuming clinical trials in the second half of this year."

About Tesetaxel

Tesetaxel is a novel, orally absorbed, semi-synthetic taxane that is in the same class of drugs as paclitaxel and docetaxel. However, both prototype agents suffer from serious safety issues, particularly hypersensitivity reactions related to intravenous infusions that are occasionally fatal and that require careful premedication and observation. Other prominent side-effects of this drug class include myelosuppression (low blood counts) and peripheral neuropathy (disabling nerve damage).

With administration as an oral capsule, tesetaxel was developed to maintain the high antitumor activity of the taxane drug class while eliminating infusion reactions, reducing neuropathy, and increasing patient convenience. The oral route also enables development of novel schedules that may expand
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated
2. iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix
3. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
4. eRT Announces the Availability of the Suicidality Monitoring System(TM) For Clinical Trials
5. The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial
6. Randomized Controlled Clinical Trial Shows Derma Sciences MEDIHONEY(TM) Eradicates MRSA From Chronic Venous Ulcers
7. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
8. Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials
9. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
10. Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain
11. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014 The western European automated endoscope ... largely a replacement market with fewer new installations ... and partnerships are redefining competitive landscape in western ... provides details about revenue forecasts, unit shipments, market ... the country. The changing landscape makes it important ...
(Date:9/22/2014)... , September 22, 2014 ... http://www.researchandmarkets.com/research/8ndtrc/freeze_drying_ ) has announced the addition of ... (Lab, Pilot, & Industrial) Market - Forecast ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ,The global freeze ... in 2014 and is expected to reach ...
(Date:9/22/2014)... September 22, 2014 Final ... 25   The second edition of the ... excited to announce the final nominations for the 2014 ... on the evening of September 25 at The Taj Mahal Palace, ... applicants based on a variety of qualitative and quantitative ...
Breaking Medicine Technology:Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 2Global Freeze Drying / Lyophilization Equipment (Lab, Pilot, & Industrial) Market - Forecast to 2019 3Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 2Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 3
...  SuccessEHS announces that its newest release will increase physician ... to previous releases.  The company has optimized features and ... and Practice Management software solution to make ... will focus on user efficiency and physician productivity ...
...  Snow tires? Check! Anti-freeze? Check! Window scraper? Check! Gloves? ... to prepare your skin for the effects of winter. ... skin that is rough, flaky, and downright unsightly. This ... it starts with AmLactin® Moisturizing Body Lotion. Wrap yourself ...
Cached Medicine Technology:Newest SuccessEHS Release to Increase Physician Software Usability 2Newest SuccessEHS Release to Increase Physician Software Usability 3Don't Let Your Skin Take a Backseat As You Prepare for Winter 2Don't Let Your Skin Take a Backseat As You Prepare for Winter 3
(Date:9/22/2014)... On Saturday, September 27, UHY LLP and UHY Cares ... is doing an amazing job helping kids and refurbishing school ... and friends will be spending the day at Academy of ... graphics, as well as clean the playground and surrounding park ... in May but due to weather conditions it was postponed ...
(Date:9/22/2014)... Sept. 22, 2014 (HealthDay News) -- Teens and young ... "intensive" behavioral counseling to help prevent risky sexual behaviors, ... Task Force. Every year, about 20 million new ... in the United States. About half involve people between ... force. Its new report, published Sept. 22 ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, ... newborn intensive care units (NICU) set up private rooms for ... finds. Researchers at one children,s hospital found that preemies ... when their NICU switched from the traditional "open-bay" layout to ... 22 in the journal Pediatrics , add to evidence ...
(Date:9/22/2014)... Malaysia today became a founding partner in the Global ... to promoting young talent in science, technology, engineering and ... New York Academy of Sciences (NYAS), Malaysian Prime Minister ... Monday Sept. 22. , With the goal of developing ... countries by 2020, the initiative will create a host ...
(Date:9/22/2014)... Recent two-generation approaches to reducing poverty that help ... from researchers, advocates, and foundations. By combining education ... move to jobs that offer a path out ... for children, these programs aim to improve the ... a new report from the National Center for ...
Breaking Medicine News(10 mins):Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 3Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:A two-generation lens: Current state policies fail to support families with young children 2
... Updated Information Provided to Customers , LANDOVER, Md., Jan. ... to pull products containing peanut butter and peanut paste ... has traced the salmonella to a plant owned by ... recalled products from our shelves including:, ...
... The association between tobacco smoke and cancer deaths ... by a recent study from a UC Davis researcher, ... lives than previously estimated. , The epidemiological analysis, published ... more than 70 percent of the cancer death burden ...
... /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) www.htdsmedical.com ... CEO. Terry is the current President and CEO of Shenzhen ... , a company targeted for a merger with HTDS. (See ... filings on Pink Sheets shortly. , Mr. Terry Yuan will ...
... to 50 million uninsuredsteeply rising insurance premiumsemployers cutting ... picture. In Disease, Diagnoses, and Dollars: Facing the ... Robert Kaplan takes America,s healthcare industry to task ... in it. , Provocative, timely, and comprehensively researched, ...
... MIAMI, Jan. 21 Financial services leader ING and the ... contest that,celebrates their success in the ING Run For Something ... The top three essays were submitted by ... Dade Middle School, 7th grade, -- Christian ...
... Favorite Body Parts: Our Faces are Fabulous; Tummies ... abs top the list of favorite and least favorite ... to a new survey conducted by American Laser Centers, ... U.S.Nearly a quarter of the men (24 percent) and ...
Cached Medicine News:Health News:Giant Food Responds to Recall of Peanut Based Products 2Health News:UC Davis study links smoking with most male cancer deaths 2Health News:Hard To Treat Diseases (HTDS) To Name New CEO and Directors 2Health News:ING and Fit Miami Foundation Name Winners of 'ING Run For Something Better' Student Essay Contest 2Health News:ING and Fit Miami Foundation Name Winners of 'ING Run For Something Better' Student Essay Contest 3Health News:ING and Fit Miami Foundation Name Winners of 'ING Run For Something Better' Student Essay Contest 4Health News:How Does Our Vanity Fare? 2
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
Minimal M9CA Broth...
Form: Cream-colored powder Moisture: 10% Ash: 6.5% Gel Strength (1.5%): 550 950 gm/cm 2 Gel pH (1.5%): 6.0 7.5 Gel Point (1.5%): 34 38C Melting Point (1.5%): 84 88C Application: Bacterial ...
...
Medicine Products: